Beryl Drugs Limited (BOM:524606)
22.90
-0.60 (-2.55%)
At close: Jun 17, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 116.14 million as of June 18, 2026. Its market cap has increased by 14.56% in one year.
Market Cap
116.14M
Enterprise Value
137.81M
Revenue
188.20M
Ranking
n/a
PE Ratio
27.26
Stock Price
22.90
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 116.14M, an increase of 3,043.80%. That is a compound annual growth rate of 17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 119.18M | 0.43% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Add-Shop E-Retail | 206.40M |
| Desh Rakshak Aushdhalaya | 199.44M |
| Zenith Healthcare | 167.67M |
| Colinz Laboratories | 146.74M |
| Ortin Global | 138.40M |
| Norris Medicines | 135.61M |
| Shamrock Industrial Company | 127.82M |
| Emmessar Biotech & Nutrition | 122.95M |